ROVESTI, GIULIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.515
AS - Asia 1.378
EU - Europa 1.300
SA - Sud America 195
Continente sconosciuto - Info sul continente non disponibili 52
AF - Africa 43
OC - Oceania 17
Totale 5.500
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.429
IT - Italia 526
SG - Singapore 409
CN - Cina 349
VN - Vietnam 196
GB - Regno Unito 182
HK - Hong Kong 146
BR - Brasile 145
DE - Germania 107
SE - Svezia 92
FI - Finlandia 70
RU - Federazione Russa 65
BD - Bangladesh 58
FR - Francia 57
CA - Canada 50
IE - Irlanda 47
KR - Corea 36
ID - Indonesia 35
IN - India 29
JP - Giappone 23
NL - Olanda 23
MX - Messico 21
TR - Turchia 21
BE - Belgio 20
AR - Argentina 18
UA - Ucraina 18
AU - Australia 16
IQ - Iraq 16
BG - Bulgaria 15
AL - Albania 14
ES - Italia 14
PK - Pakistan 11
ZA - Sudafrica 11
AT - Austria 10
CO - Colombia 9
PL - Polonia 8
CZ - Repubblica Ceca 7
MY - Malesia 7
AE - Emirati Arabi Uniti 6
EC - Ecuador 6
CL - Cile 5
KE - Kenya 5
LT - Lituania 5
MA - Marocco 5
AZ - Azerbaigian 4
EG - Egitto 4
JM - Giamaica 4
NG - Nigeria 4
NP - Nepal 4
TN - Tunisia 4
VE - Venezuela 4
BO - Bolivia 3
BY - Bielorussia 3
BZ - Belize 3
CH - Svizzera 3
IR - Iran 3
OM - Oman 3
PE - Perù 3
RO - Romania 3
RS - Serbia 3
SA - Arabia Saudita 3
SI - Slovenia 3
TW - Taiwan 3
UZ - Uzbekistan 3
BW - Botswana 2
CR - Costa Rica 2
DZ - Algeria 2
GE - Georgia 2
KZ - Kazakistan 2
PA - Panama 2
PT - Portogallo 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
CI - Costa d'Avorio 1
CM - Camerun 1
CY - Cipro 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
EU - Europa 1
GH - Ghana 1
GR - Grecia 1
HR - Croazia 1
JO - Giordania 1
LK - Sri Lanka 1
MD - Moldavia 1
ML - Mali 1
MN - Mongolia 1
MQ - Martinica 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PY - Paraguay 1
QA - Qatar 1
TH - Thailandia 1
UY - Uruguay 1
Totale 5.449
Salva come PNG Salva come JPEG
Città #
Ashburn 293
Singapore 279
Santa Clara 263
Fairfield 185
Chandler 145
Hong Kong 134
San Jose 133
Houston 89
Modena 80
Hefei 77
Wilmington 77
Council Bluffs 75
Southend 75
Seattle 73
Woodbridge 72
Beijing 65
Nyköping 65
Bologna 63
New York 61
Cambridge 60
Ann Arbor 59
Helsinki 58
London 57
Los Angeles 53
Ho Chi Minh City 51
Dublin 46
Hanoi 44
The Dalles 41
Milan 40
Munich 34
Seoul 34
Jakarta 30
Dearborn 29
Dallas 28
Jacksonville 24
San Diego 22
Chicago 21
Toronto 21
Orem 20
Buffalo 19
Reggio Emilia 19
Bremen 16
Brussels 16
Fremont 16
Shanghai 16
Princeton 15
Sofia 15
Florence 14
Lauterbourg 14
Moscow 14
Boardman 13
Da Nang 13
Frankfurt am Main 13
Brooklyn 11
Guangzhou 11
Phoenix 11
San Giuliano Milanese 11
São Paulo 11
Dong Ket 10
Rome 10
Tirana 10
Turku 10
Haiphong 9
Hangzhou 9
Montreal 9
Mumbai 9
Tokyo 9
Adelaide 8
Atlanta 8
Chennai 8
Eugene 8
Falls Church 8
Mexico City 8
Parma 8
Amsterdam 7
Columbus 7
Denver 7
Izmir 7
Naples 7
Redondo Beach 7
Salt Lake City 7
Shinjuku 7
Genoa 6
Johannesburg 6
Redwood City 6
Rio de Janeiro 6
Vienna 6
Warsaw 6
Aydin 5
Can Tho 5
Fidenza 5
Grimes 5
Nuremberg 5
Ottawa 5
Padova 5
Paris 5
Stockholm 5
Turin 5
Vicenza 5
Baghdad 4
Totale 3.636
Salva come PNG Salva come JPEG
Nome #
Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic Cancer 427
Inducible Caspase9-mediated suicide gene for MSC-based cancer gene therapy 426
MSC-delivered soluble TRAIl and paclitaxel as novel combinatory treatment for pancreatic adenocarcinoma 422
SOLUBLE TRAIL-ARMED HUMAN AD-MSC AS NOVEL CELL THERAPY APPROACH FOR PANCREATIC DUCTAL ADENOCARCINOMA 381
Axillary Ectopic Carcinoma of the Breast. Report of Two Cases with Different Clinical Presentation and Review of the Literature. 357
ANGPT2 and NOS3 Polymorphisms and Clinical Outcome in Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib 279
Management of adverse events with tailored sorafenib dosing prolongs survival of hepatocellular carcinoma patients 279
1H-NMR based serum metabolomics highlights different specific biomarkers between early and advanced hepatocellular carcinoma stages 278
Autologous anti-GD2 CAR T cells efficiently target primary human glioblastoma 256
Immunotherapy: ANTI-GD2 CAR T CELLS AGAINST SMALL CELL LUNG CANCER 243
Clinical implications of malnutrition in the management of patients with pancreatic cancer: Introducing the concept of the nutritional oncology board 233
TRAIL receptors are expressed in both malignant and stromal cells in pancreatic ductal adenocarcinoma 232
The growing skyline of advanced hepatocellular carcinoma treatment: A review. 222
Immunotherapy: AUTOLOGOUS ANTI-GD2 CAR T CELLS EFFICIENTLY TARGET PRIMARY HUMAN GLIOBLASTOMA 198
Chapter 8 - Hybrid polymeric scaffolds for brain applications: locoregional glioblastoma therapy 174
Impact of Baseline Characteristics on the Overall Survival of HCC Patients Treated with Sorafenib: Ten Years of Experience 165
Could inflammatory indices and metabolic syndrome predict the risk of cancer development? Analysis from the bagnacavallo population study 158
Prognostic Role of a New Index (RAPID Index) in Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib: Training and Validation Cohort 156
BRCA in Gastrointestinal Cancers: Current Treatments and Future Perspectives 148
Utility of neutrophil-to-lymphocyte ratio to identify long-term survivors among HCC patients treated with sorafenib 144
Retrospective survival analysis in patients with metastatic pancreatic ductal adenocarcinoma with insulin-treated type 2 diabetes mellitus 135
External validation of surrogate indices of fatty liver in the general population: The Bagnacavallo study 134
CAR-T for Lung Cancers: Challenges and Innovations 53
Totale 5.500
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.580
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.580
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022395 25 36 21 8 26 54 28 25 26 34 81 31
2022/2023494 63 56 28 46 48 48 9 51 85 7 27 26
2023/2024267 8 12 18 28 33 40 9 27 9 17 22 44
2024/20251.291 24 24 61 121 206 212 115 78 151 73 98 128
2025/20262.097 165 64 115 239 285 124 290 105 226 253 164 67
2026/202750 50 0 0 0 0 0 0 0 0 0 0 0
Totale 5.500